Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0001567619-22-008369

Options or other derivatives

  • Chief Development Officer acquired 247,841 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Bigora Sian Chief Development Officer 2022-04-01 Grant or award · Restricted Stock Units +247,841 302,766 D: show line 1 in the form
Loading xslF345X03/doc1.xml…